The Discounted Cash Flow (DCF) valuation of Biodesix, Inc. (BDSX) is (8.97) USD. With the latest stock price at 0.32 USD, the upside of Biodesix, Inc. based on DCF is -2938.4%.
Based on the latest price of 0.32 USD and our DCF valuation, Biodesix, Inc. (BDSX) is a sell. selling Biodesix, stocks now will result in a potential gain of 2938.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 9.6% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (54.92) - (5.08) | (8.97) |
| Upside | -17472.8% - -1705.6% | -2938.4% |